Developing vaccines for infectious diseases including SARS-CoV-2
V25: PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS-COV-2
['FUNDING_OTHER'] · INTERNATIONAL AIDS VACCINE INITIATIVE · NIH-10168830
This study is working on creating new vaccines to help protect people from serious infections, especially those that could be used in bioterrorism or are coming back, so that patients can have better options for staying healthy.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INTERNATIONAL AIDS VACCINE INITIATIVE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10168830 on ClinicalTrials.gov |
What this research studies
This research focuses on the development and manufacturing of vaccines and biologics aimed at combating infectious diseases, particularly those that pose a threat of bioterrorism or are emerging and re-emerging. The project includes planning and feasibility assessments, product optimization, and compliance with regulatory standards for clinical studies. Patients may benefit from the development of new vaccines that could protect against serious infections. The research also involves the production of vaccine components and delivery systems.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for infectious diseases, particularly those related to bioterrorism or emerging infections.
Not a fit: Patients who are not at risk for infectious diseases or those who have already been vaccinated against the specific pathogens being targeted may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the introduction of effective vaccines that protect against infectious diseases, improving public health outcomes.
How similar studies have performed: Other research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising approach.
Where this research is happening
NEW YORK, UNITED STATES
- INTERNATIONAL AIDS VACCINE INITIATIVE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HASSEL, THOMAS — INTERNATIONAL AIDS VACCINE INITIATIVE
- Study coordinator: HASSEL, THOMAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder